ASAM TOUD and REMS Course | 2023

CONTINUING NURSING EDUCATION IS PROVIDING THE REMS COURSE PRODUCED BY THE AMERICAN SOCIETY OF ADDICTION MEDICINE

(REMS) Pain Management and Opioids: Mitigating Risks and Benefits

FORMAT: Self-paced on-demand course (available until 12/31/2023)
DATE: As soon as you have registered through the ASAM website, you will get access. 
TOTAL CE H: 4.00 Hours
PRICE: free of charge 

Registration link: Pain Management and Opioids: Balancing Risks and Benefits 2023

Description:

The Pain Management and Opioids: Mitigating Risks (REMS) course is a 4-hour course designed to educate ER/LA opioid prescribers about the necessary context for safe opioid prescribing. This newly updated comprehensive course discusses the opioid overdose death epidemic, biopsychosocial aspects of pain and addiction, and clinical guidelines on the treatment of chronic pain. This program meets many states’ requirements for opioid education. It is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blue Print”), issued by the U.S. Food & Drug Administration in September 2018.

CONTINUING NURSING EDUCATION IS FACILITATING THE TOUD COURSE PRODUCED BY THE AMERICAN SOCIETY OF ADDICTION MEDICINE (this course is closed)

Registration is done through the website of ASAM and after the course, they also provide the Certificate. UWCNE facilitates the live ZOOM TOUD Conference. The REMS Course is a self-paced 4-hour course.   Both courses have different registration links, more information is below. 

TOUD Course (Treatment of Opioid Use Disorder Course) | Course in Addiction Medicine

FORMAT: Virtual Conference through ZOOM
DATE: May 25, 2023
HOURS: 8:00 AM – 5:00 pm
TOTAL CE HOURS: 8.00
PRICE: free of charge

Registration link: ASAM eLearning: Treatment of Opioid Use Disorder – UW- School of Nursing – Thursday, May 25, 2023

The virtual live course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices and also provides the required education needed to obtain the waiver to prescribe buprenorphine. This course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. The target audience for this introductory-level course includes Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder. This activity addresses the following ACGME Competencies: Patient Care and Medical Knowledge.

Learning Objectives

Upon completion, learners will be able to:

1. Identify, assess, and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities
2. Develop an individualized, patient-centered treatment plan including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options
3. Monitor progress and modify treatment plan based on patient needs and progress toward treatment goals
4. Implement best practices for office systems including team-based care to support treatment with medications for opioid use disorder
5. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder